Etravirine 200-mg Formulation Available in UK
On 17 January 2012, Janssen announced the launch of a 200 mg formulation of the NNRTI etravirine (Intelence).
The recommended oral dose of 200 mg etravirine is one tablet taken twice daily following a meal. The previous formulation required 2 x 100 mg twice-daily.
These tablets are dispersible in a glass of water. This option may be important given the new pill is slightly larger than the 100 mg formulation (22 mm vs 19 mm long).
The monthly list price for the 200 mg formulation is matched to the current daily price for the 100 mg formulation at £301.27.
Source: Janssen PR: Janssen launches 200mg etravirine (Intelence) for anti-retroviral treatment-experienced adults with HIV-1 (17 January 2012).
Links to external websites are current at time of posting but not maintained.
Intelence (Etravirine): Pediatric Dosing Recommendations and New Scored 25 mg Tablet for Pediatric Dosing
This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)